BRANDES INVESTMENT PARTNERS, LP - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 186 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
BRANDES INVESTMENT PARTNERS, LP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$14,879,000
-4.5%
4,723,376
-11.7%
0.51%
+8.4%
Q2 2020$15,572,000
-3.7%
5,351,132
-6.7%
0.47%
-16.3%
Q1 2020$16,169,000
-14.3%
5,733,572
-1.3%
0.57%
+26.3%
Q4 2019$18,857,000
+59.7%
5,811,080
+6.3%
0.45%
+46.9%
Q3 2019$11,805,000
-9.9%
5,465,156
+31.0%
0.30%
+4.5%
Q2 2019$13,100,000
-19.0%
4,171,971
-4.0%
0.29%
-22.3%
Q1 2019$16,164,000
+24.9%
4,345,083
-2.6%
0.38%
+13.9%
Q4 2018$12,943,000
+25.0%
4,463,103
+13.4%
0.33%
+41.0%
Q3 2018$10,354,000
+1522.9%
3,936,719
+1343.0%
0.23%
+1571.4%
Q2 2018$638,000
-73.5%
272,811
-66.8%
0.01%
-72.5%
Q1 2018$2,412,000
-20.0%
820,741
-25.4%
0.05%
-16.4%
Q4 2017$3,016,000
-20.0%
1,100,518
-1.1%
0.06%
-20.8%
Q3 2017$3,772,000
+31.0%
1,112,679
+0.5%
0.08%
+67.4%
Q2 2017$2,879,000
+2064.7%
1,107,310
+1790.3%
0.05%
+2200.0%
Q1 2017$133,00058,5780.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2017
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders